Quick Answer
Phathom Pharmaceuticals, Inc. reported Total Assets of $259.15 million for fiscal year 2025.
Phathom Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $259.15M | -31.5% |
| 2024 | $378.32M | -8.6% |
| 2023 | $413.84M | +151.1% |
| 2022 | $164.81M | -13.0% |
| 2021 | $189.43M | -35.8% |
| 2020 | $295.11M | +14.7% |
| 2019 | $257.18M | +28412.0% |
| 2018 | $902.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $240.29M | -37.9% | -4.0% |
| June 30, 2025 | $250.22M | -21.7% | -15.0% |
| March 31, 2025 | $294.21M | -17.5% | -22.2% |
| December 31, 2024 | $378.32M | -8.6% | -2.3% |
| September 30, 2024 | $387.04M | +63.3% | +21.2% |
| June 30, 2024 | $319.38M | +20.5% | -10.4% |
| March 31, 2024 | $356.50M | +147.6% | -13.9% |
| December 31, 2023 | $413.84M | +151.1% | +74.6% |
- Phathom Pharmaceuticals, Inc. showed a decrease of -31.5% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Phathom Pharmaceuticals, Inc.’s total assets has grown by 28630.5% (from $902.0 thousand to $259.15 million).
- The most recent figure is from Phathom Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: